|
[1]Blei AT, Cordoba J.Hepatic Encephalopathy[J].Am J Gastroenterol, 2001, 96 (7) ∶1968-1976.
|
|
[2]Ferenci P, Lockwood A, Mullen K, et al.Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification:final report of the working party at the11th World Congresses of Gastroenterology, Vienna, 1998[J].Hepatology, 2002, 35 (3) ∶716721.
|
|
[3]肝性脑病诊断治疗专家委员会.肝性脑病诊断治疗专家共识[J].中华实验和临床感染病杂志 (电子版) , 2009, 3 (4) ∶449-473.
|
|
[4]涂传涛.肝性脑病的诊断方法及其研究进展[J].实用肝脏病杂志, 2009, 12 (2) ∶158-160.
|
|
[5]颜迎春, 张明香.肝性脑病的现代治疗[J].中国现代医生, 2008, 46 (10) ∶22-23.
|
|
[6]白启轩, 贾继东.肝性脑病的研究进展[J].现代消化及介入诊疗, 2009, 14 (1) ∶29-32.
|
|
[7]Cordoba J, Raguer N, Flavia M, et al.T2hyperintensity along the cortico-spinal tract in cirrhosis relates to functional abnormalities[J].Hepatology, 2003, 38 (4) ∶1026-1033.
|
|
[8]Clemmesen JO, Larsen FS, Kondrup J, et al.Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration[J].Hepatology, 1999, 29 (3) ∶648-653.
|
|
[9]Blei AT.The pathophysiology of brain edema in acute liver failure[J].Neurochem Int, 2005, 47 (1-2) :71-77.
|
|
[10]王秋实, 刘辉, 梁长虹.33例活体肝脏磁共振氢质子波谱分析[J].山东医药, 2007, 47 (23) ∶67-68.
|
|
[11]Huda A, Guze BH, Thomas A, et al.Clinical correlation of neuropsychological tests with1H magnetic resonance spectroscopy in hepatic encephalopathy[J].Psychosom Med, 1998, 60 (5) ∶550556.
|
|
[12]Yazgan Y, Narin Y, Demirturk L, et al.Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy[J].J Gastroenterol Hepatol, 2003, 18 (10) ∶1162-1167.
|
|
[13]Rovira A, Alonso J, Cordoba J.MR imaging findings in hepatic encephalopathy[J].AJNR Am J Neuroradiol, 2008, 29 (9) ∶16121621.
|
|
[14]Haussinger D, Schliess F.Pathogenetic mechanisms of hepatic encephalopathy[J].Gut, 2008, 57 (8) ∶1156-1165.
|
|
[15]Bjerring PN, Eefsen M, Hansen BA, et al.The brain in acute liver failure.A tortuous path from hyperammonemia to cerebral edema[J].Metab Brain Dis, 2009, 24 (1) ∶5-14.
|
|
[16]Manley GT, Fujimura M, Ma T, et al.Aquaporin-4deletion in mice reduces brain edema after acute water intoxication and ischemic stroke[J].Nat Med, 2000, 6 (2) ∶159-163.
|
|
[17]Papadopoulos MC, Verkman AS.Aquaporin-4and brain edema[J].Pediatr Nephrol, 2007, 22 (6) ∶778-784.
|
|
[18]Ellis AJ, Wendon JA, Williams R.Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure:a controlled clinical trial[J].Hepatology, 2000, 32 (3) ∶536-541.
|
|
[19]Bhatia V, Batra Y, Acharya SK.Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial[J].J Hepatol, 2004, 41 (1) ∶89-96.
|
|
[20]Walsh TS, Hopton P, Philips BJ, et al.The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure[J].Hepatology, 1998, 27 (5) ∶1332-1340.
|
|
[21]Strauss G, Hansen BA, Knudsen GM, et al.Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure[J].J Hepatol, 1998, 28 (2) ∶199-203.
|
|
[22]Shimomura Y, Honda T, Goto H, et al.Effects of liver failure on the enzymes in the branched-chain amino acid catabolic pathway[J].Biochem Biophys Res Commun, 2004, 313 (2) ∶381-385.
|
|
[23]Honda T, Fukuda Y, Nakano I, et al.Effects of liver failure on branched-chain alpha-keto acid dehydrogenase complex in rat liver and muscle:comparison between acute and chronic liver failure[J].J Hepatol, 2004, 40 (3) ∶439-445.
|
|
[24]Cordoba J, Lucke R.Driving under the influence of minimal hepatic encephalopathy[J].Hepatology, 2004, 39 (3) ∶599-601.
|
|
[25]Cordoba J, Lopez-Hellin J, Planas M, et al.Normal protein diet for episodic hepatic encephalopathy:results of a randomized study[J].J Hepatol, 2004, 41 (1) ∶38-43.
|
|
[26]Merli M, Riggio O.Dietary and nutritional indications in hepatic encephalopathy[J].Metab Brain Dis, 2009, 24 (1) ∶211-221.
|
|
[27]Ahmad I, Khan AA, Alam A, et al.L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy[J].J Coll Physicians Surg Pak, 2008, 18 (11) ∶684-687.
|
|
[28]Poo JL, Gongora J, Sanchez-Avila F, et al.Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.Results of a randomized, lactulose-controlled study[J].Ann Hepatol, 2006, 5 (4) ∶281-288.
|
|
[29]Acharya SK, Bhatia V, Sreenivas V, et al.Efficacy of L-ornithine L-aspartate in acute liver failure:a double-blind, randomized, placebo-controlled study[J].Gastroenterology, 2009, 136 (7) ∶2159-2168.
|
|
[30]Soarez PC, Oliveira AC, Padovan J, et al.A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment[J].Arq Gastroenterol, 2009, 46 (3) ∶241-247.
|
|
[31]Jiang Q, Jiang XH, Zheng MH, et al.L-Ornithine-l-aspartate in the management of hepatic encephalopathy:a meta analysis[J].J Gastroenterol Hepatol, 2009, 24 (1) ∶9-14.
|
|
[32]Jalan R, Wright G, Davies NA, et al.L-Ornithine phenylacetate (OP) :a novel treatment for hyperammonemia and hepatic encephalopathy[J].Med Hypotheses, 2007, 69 (5) ∶1064-1069.
|
|
[33]Davies NA, Wright G, Ytrebo LM, et al.L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats[J].Hepatology, 2009, 50 (1) ∶155164.
|
|
[34]Ytrebo LM, Kristiansen RG, Maehre H, et al.L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure[J].Hepatology, 2009, 50 (1) ∶165-174.
|
DownLoad: